Technical Analysis for LAB - Standard BioTools Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Outside Day | Range Expansion | 0.00% | |
| NR7 | Range Contraction | 2.80% | |
| Gapped Up | Strength | 1.58% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 1.18% | |
| Crossed Above 20 DMA | Bullish | 1.18% | |
| MACD Bullish Signal Line Cross | Bullish | 1.18% | |
| Pocket Pivot | Bullish Swing Setup | 1.18% | |
| 20 DMA Resistance | Bearish | 3.63% | |
| Crossed Above 200 DMA | Bullish | 3.63% | |
| 200 DMA Resistance | Bearish | 7.08% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 1 day ago |
| Outside Day | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
Get this analysis on your stocks daily!
- Earnings date: 05/08/2024
Standard BioTools Inc. Description
Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Disease Natural Sciences Immunotherapy Medical Research Flow Cytometry
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.16 |
| 52 Week Low | 1.57 |
| Average Volume | 2,675,347 |
| 200-Day Moving Average | 2.43 |
| 50-Day Moving Average | 2.60 |
| 20-Day Moving Average | 2.47 |
| 10-Day Moving Average | 2.45 |
| Average True Range | 0.13 |
| RSI (14) | 53.49 |
| ADX | 14.12 |
| +DI | 23.12 |
| -DI | 20.61 |
| Chandelier Exit (Long, 3 ATRs) | 2.26 |
| Chandelier Exit (Short, 3 ATRs) | 2.56 |
| Upper Bollinger Bands | 2.63 |
| Lower Bollinger Band | 2.31 |
| Percent B (%b) | 0.81 |
| BandWidth | 13.05 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.04 |
| MACD Histogram | 0.0188 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.73 | ||||
| Resistance 3 (R3) | 2.72 | 2.65 | 2.70 | ||
| Resistance 2 (R2) | 2.65 | 2.61 | 2.66 | 2.69 | |
| Resistance 1 (R1) | 2.61 | 2.59 | 2.63 | 2.62 | 2.68 |
| Pivot Point | 2.55 | 2.55 | 2.56 | 2.55 | 2.55 |
| Support 1 (S1) | 2.51 | 2.51 | 2.53 | 2.52 | 2.46 |
| Support 2 (S2) | 2.44 | 2.48 | 2.45 | 2.45 | |
| Support 3 (S3) | 2.40 | 2.44 | 2.44 | ||
| Support 4 (S4) | 2.41 |
